Definition and Overview
Somatic symptom disorder (SSD) is a diagnostic category reorganized in DSM-5 (2013) by consolidating the previously separate diagnoses of somatization disorder, undifferentiated somatoform disorder, pain disorder, and some cases of hypochondriasis [1]. Unlike DSM-IV, which required symptoms to be "medically unexplained," DSM-5 SSD can be diagnosed even when a medical cause exists, provided the psychological response to symptoms is excessive [1].
SSD occurs in approximately 5–7% of the general population, and in primary care settings, about 5–10% of patients meet criteria for SSD [2]. It is approximately twice as common in women as in men and most frequently presents after middle age [2]. Healthcare utilization rates are high, medical expenditures are increased, and functional impairment and reduced quality of life are prominent.
Diagnostic Criteria
The DSM-5 diagnostic criteria are as follows [1].
- A. One or more somatic symptoms that are distressing or result in significant disruption of daily life. B. Excessive thoughts, feelings, or behaviors related to the somatic symptoms or associated health concerns, as manifested by at least one of the following: (1) disproportionate and persistent thoughts about the seriousness of symptoms; (2) persistently high level of anxiety about health or symptoms; (3) excessive time and energy devoted to these symptoms or health concerns. C. Although any one somatic symptom may not be continuously present, the state of being symptomatic is persistent (typically more than 6 months).
Relationship with the Autonomic Nervous System
Stress and psychological conflict can be converted into somatic symptoms through the autonomic nervous system. HPA axis activation triggers cortisol release, and sympathetic hyperactivity induces various somatic responses.
Central sensitization is one of the key neurobiological mechanisms of somatic symptom disorder [3]. Chronic stress and psychological arousal alter pain regulatory systems in the spinal cord and brain, causing normal bodily sensations to be interpreted as pain or discomfort. This is a mechanism shared with fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome.
Heart rate variability (HRV) studies consistently report that SSD patients have lower HRV than healthy controls, with particularly reduced parasympathetic indices [3]. This is associated with impaired emotional regulation capacity and may serve as a biomarker for predicting treatment response.
Association with Functional Somatic Syndromes
Somatic symptom disorder overlaps with numerous functional somatic syndromes [3]. Fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, persistent postural-perceptual dizziness (PPPD), non-cardiac chest pain, chronic low back pain, and some cases of tension-type headache are included in or co-occur with the SSD spectrum [3]. These conditions share autonomic nervous system dysfunction and central sensitization as common mechanisms [3].
Functional neurological symptom disorder (formerly conversion disorder) involves neurological symptoms such as paralysis, tremor, seizures, and visual or speech disturbances arising from functional mechanisms. Although classified separately from SSD, it is related.
Treatment
A Cochrane review has confirmed that cognitive behavioral therapy (CBT) is effective in reducing SSD symptoms [4]. Graduated increases in physical activity, improved sleep hygiene, and stress management techniques also contribute to symptom improvement.
Mindfulness-based cognitive therapy (MBCT) and acceptance and commitment therapy (ACT) are also used in SSD treatment [3]. Psychoeducation -- explaining the mechanisms of somatic symptoms in a way patients can understand -- is important for enhancing treatment motivation.
For pharmacotherapy, tricyclic antidepressants (TCAs, especially amitriptyline) and SSRIs/SNRIs are effective for improving pain, fatigue, and mood [3]. Treatment of comorbid depression and anxiety also contributes to SSD symptom improvement.
The quality of the physician-patient relationship has a strong influence on treatment outcomes. An approach that acknowledges and empathizes with symptoms while collaboratively setting goals for functional recovery is essential [3].